SCHEMBL6294148

SCHEMBL6294148

O=c1[nH]c(=O)n(COCCOP(=O)(O)O)cc1F

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 4/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ GRIA1 P42261 1/20 0.44
▸ GRIA2 P42262 1/20 0.44
▸ GRIA3 P42263 1/20 0.44
▸ GRIA4 P48058 1/20 0.44
▸ GRIK5 Q16478 1/20 0.44
▸ LMNA P02545 2/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ PNP P00491 2/20 0.41
▸ POLG P54098 1/20 0.40
▸ UPP1 Q16831 1/20 0.40
▸ TYMP P19971 1/20 0.39
▸ NT5E P21589 1/20 0.38
▸ P2RY6 Q15077 1/20 0.38
▸ P2RY14 Q15391 1/20 0.38
▸ CA12 O43570 1/20 0.37
▸ CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3786418 0.81 UPP1 (0.57) KDM4ECYP1A2GRIA1GRIA2GRIA3
SCHEMBL13650209 0.78 LMNA (0.50) KDM4ECYP1A2GRIA1GRIA2GRIA3
SCHEMBL11099078 0.78 LMNA (0.51) KDM4ECYP1A2GRIA1GRIA2GRIA3
SCHEMBL3863318 0.77 KDM4E (0.44) ENPP1KDM4ECYP1A2GRIA1GRIA2
SCHEMBL5017332 0.76 LMNA (0.49) KDM4ECYP1A2GRIA1GRIA2GRIA3
SCHEMBL11399957 0.74 SMN1; SMN2 (0.52) KDM4ECYP1A2GRIA1GRIA2GRIA3
SCHEMBL10479252 0.74 LMNA (0.44) KDM4ECYP1A2GRIA1GRIA2GRIA3
SCHEMBL6372044 0.74 LMNA (0.56) KDM4ECYP1A2GRIA1GRIA2GRIA3
SCHEMBL11397970 0.73 SMN1; SMN2 (0.51) KDM4ECYP1A2GRIA1GRIA2GRIA3
SCHEMBL10479219 0.72 LMNA (0.42) KDM4ECYP1A2GRIA1GRIA2GRIA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6896871-B2 Biphosphonate conjugates and methods of making and using the same MBC RESEARCH, INC. (US) 2005-05-24 — — US disclosed
US-20020142994-A1 Bisphosphonate conjugates and methods of making and using the same MBC PHARMA, INC. 2002-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020142994-A1 Bisphosphonate conjugates and methods of making and using the same SOST, BPGM, PTH1R ENPP1 26/4885KDM4E 3027/4885CYP1A2 3877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback